| Financial Year |
March 31 2019 |
| Monetary Funds |
14,825,987.34 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
2,004,274.50 |
| Accounts Receivable |
237,055,399.77 |
| Advances to Suppliers |
13,085,960.41 |
| Other Receivables |
57,067,229.76 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
55,055,191.22 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,625,445.15 |
| Total Current Assets |
382,719,488.15 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,650,000.00 |
| Long-term Equity Investment |
42,552,931.19 |
| Investment Properties |
3,362,256.75 |
| Fixed Assetes |
359,417,367.54 |
| Under-construction Projects |
45,228,798.90 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
30,814,597.76 |
| R&D expenses |
-- |
| Goodwill |
9,214,868.61 |
| Long-Term Deferred and Prepaid Expenses |
82,658,830.65 |
| Deferred Income Tax Assets |
67,743,161.20 |
| Other Non-Current Assets |
556,495,788.93 |
| Sub-Total of Non-Current Assets |
1,199,138,601.53 |
| Total Assets |
1,581,858,089.68 |
| Short-Term Loans |
639,433,212.44 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
-- |
| Accounts Received In Advance |
19,909,638.73 |
| Employee Compensation Payable |
37,143,795.80 |
| Taxes Payable |
141,186,202.02 |
| Interest Payable |
374,527,000.11 |
| Dividend Payable |
-- |
| Other payables |
920,332,971.42 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
515,504,388.10 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
2,420,490,416.79 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,200,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
266,914,183.01 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
270,629,615.71 |
| Total Liabilities |
2,691,120,032.50 |
| Paid-In Capital(Or Share Stock) |
635,258,156.00 |
| Capital Surplus |
-- |
| Surplus Reserve |
18,614,200.40 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,821,647,757.89 |
| Minority Stockholder's Interest |
43,281,475.10 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-1,152,543,417.92 |
| Owner's Equity（Stockholder's Equity） |
-1,109,261,942.82 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,581,858,089.68 |
